High levels of adrenomedullin found to promote obesity-associated insulin resistance

Adrenomedullin (ADM) inhibits endothelial insulin signaling, contributing to obesity-associated insulin resistance, according to research conducted by the Max Planck Institute for Heart and Lung Research in Germany.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup